Toggle SGML Header (+)


Section 1: 8-K (8-K)

caci-8k_20191001.htm
false CACI INTERNATIONAL INC /DE/ 0000016058 0000016058 2019-10-01 2019-10-01

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): October 1, 2019

 

CACI International Inc

(Exact name of Registrant as Specified in Its Charter)

 

 

Delaware

001-31400

54-1345888

(State or Other Jurisdiction

of Incorporation)

(Commission File Number)

(IRS Employer

Identification No.)

 

 

 

1100 N. Glebe Road

Arlington, Virginia

 

22201

(Address of Principal Executive Offices)

 

(Zip Code)

Registrant’s Telephone Number, Including Area Code: (703) 841-7800

Not Applicable

(Former Name or Former Address, if Changed Since Last Report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instructions A.2. below):

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

 

 

 

Emerging growth company

 

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class

Trading Symbol(s)

Name of each exchange on which registered

Common Stock

CACI

New York Stock Exchange

 

 

 

 

 


Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

 

On October 1, 2019, the Compensation Committee of the Board of Directors (the “Compensation Committee”) of CACI International Inc (the “Company”) approved a one-time special award of performance-based restricted stock units (“PRSUs”) to Dr. J.P. London, the Company’s Executive Chairman and Chairman of the Board of Directors. The award consists of 8,844 PRSUs, with a grant date value of approximately $2,000,000, which will be earned if the Company achieves a certain earnings per share target for fiscal year 2021. If earned, the PRSUs will vest on October 1, 2021.

 

On October 1, 2019, the Compensation Committee approved a one-time special award of restricted stock units (“RSUs”) to DeEtte Gray, the Company’s President, Business and Information Technology Solutions. The award consists of 8,844 RSUs, with a grant date value of approximately $2,000,000, which will vest on October 1, 2022.

 

The awards to Dr. London and Ms. Gray are subject to the terms and conditions of Company’s 2016 Incentive Compensation Plan and their respective award agreements.

 

 


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

 

 

CACI International Inc

 

 

 

 

Date: October 7, 2019

 

By:

/s/ J. William Koegel, Jr.

 

 

 

J. William Koegel, Jr.

 

 

 

Executive Vice President, General Counsel and Secretary

 

 

 

 

(Back To Top)